ABUS

#2131
Arbutus Biopharma Corporation - Common Stock
4.5 6 USD
-0.87%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
4.53
4.58
Range Annuel
3.04
5.10
Changement quotidien
-0.87%
Changement Mensuel
+10.41%
Evolution sur 6 mois
+5.07%
Changement Annuel
+33.33%
Clôture Précédente
4.6 0
Open
4.5 7
Low
4.5 3
High
4.5 8
Volume
635
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
  • Market Capitalization 900.77 M
  • Employee 19
  • Founded 2007
  • CEO William H. Collier
  • Website www.arbutusbio.com
  • Headquarter British Columbia, Canada
  • FIGI BBG000RR8V85
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-28.29
ratio cours/chiffre d'affaires
65.44

Arbutus Biopharma Corporation - Common Stock

Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection. It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007.

Nouvelles